Market Tracker

11/21 6:05pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

14.29
Data as of Nov 21
 -0.22 / -1.52%
Today’s Change
12.50
Today|||52-Week Range
21.40
-27.09%
Year-to-Date

Today’s Trading

Previous close14.51
Today’s open14.67
Day’s range14.00 - 14.67
Volume401,654
Average volume (3 months)238,586
Market cap$375.7M
Dividend yield--
Data as of 4:00pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+7.32%
Earnings growth (this year)-940.79%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.82%
P/E ratioNM
Price/Sales34.19
Price/Book2.02

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...-0.10-1.11%
RVNCRevance Therapeutics...+0.36+2.24%
TKMRTekmira Pharmaceutic...-0.11-0.68%
ZIOPZIOPHARM Oncology In...+0.15+4.04%
Data as of 4:00pm ET, 11/21/2014

Financials

Next reporting dateMarch 3, 2015
EPS forecast (this quarter)-$1.07
Annual revenue (last year)$11.3M
Annual profit (last year)-$66.7M
Net profit margin-593.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts